Charcot-Marie-Tooth 2B mutations in rab7 cause dosage-dependent neurodegeneration due to partial loss of function.
about
A brief review of recent Charcot-Marie-Tooth research and prioritiesRab13 Traffics on Vesicles Independent of Prenylation.Maintenance of glia in the optic lamina is mediated by EGFR signaling by photoreceptors in adult Drosophila.Regulation of Notch signaling and endocytosis by the Lgl neoplastic tumor suppressor.Beclin 1 regulates neuronal transforming growth factor-β signaling by mediating recycling of the type I receptor ALK5.Charcot-Marie-Tooth 2b associated Rab7 mutations cause axon growth and guidance defects during vertebrate sensory neuron developmentStem-cell-specific endocytic degradation defects lead to intestinal dysplasia in DrosophilaThe Ccz1-Mon1-Rab7 module and Rab5 control distinct steps of autophagy.Fly model causes neurological rethink.Charcot Marie Tooth 2B Peripheral Sensory Neuropathy: How Rab7 Mutations Impact NGF Signaling?Hypomyelination and developmental delay associated with VPS11 mutation in Ashkenazi-Jewish patients.Endocytosis regulates TDP-43 toxicity and turnover.Rab2 promotes autophagic and endocytic lysosomal degradation.Consequences of Rab GTPase dysfunction in genetic or acquired human diseases.The where, what, and when of membrane protein degradation in neurons.Lipophagy prevents activity-dependent neurodegeneration due to dihydroceramide accumulation in vivo.Alterations of autophagy in the peripheral neuropathy Charcot-Marie-Tooth type 2B.Neuronal lysosomes.Live Observation of Two Parallel Membrane Degradation Pathways at Axon Terminals.Rab GTPases and Membrane Trafficking in Neurodegeneration.Degradation of dendritic cargos requires Rab7-dependent transport to somatic lysosomes
P2860
Q27012700-FB8703C4-B3D6-49D0-8F5C-BC3FF601B4BBQ30756731-655BBD18-8F6B-427B-B83D-14D4FDED32ACQ35536431-8CB3BB08-D0A7-42C5-AB80-50F3BA616C72Q36185779-DC194210-3F3B-4419-9A01-518BB0ECD464Q36393176-44F033F5-8D4A-44AC-9189-0D9ACD339738Q36485921-07194948-0357-4575-B0CF-9B3244296CA2Q36967511-369BAE8B-E4FA-4BB7-9B10-85188E5FE4F3Q37338268-B56A4A73-C75E-4145-A73F-2E99F1B1411DQ37383339-76BFA05F-EFC1-4BE5-9FB5-F7F730A77212Q39122072-1E73C9EF-1F82-4E3B-86FD-A4810FD99787Q41927557-36301DE3-1771-4612-9A23-E3C8DE9031ECQ47108096-65D1259E-FEA3-4A7E-8BAB-D9CB9E6F61E6Q47160303-1FD589AD-B89A-4C2D-B8CC-32F67577746FQ47294747-25D84F1C-7B4B-4765-AED2-1762F0A68F61Q47836274-3FEA6B62-F4F3-46AE-B847-AC52D7C67C51Q48141984-B9663431-B1B8-4898-B860-4F1C35E57C59Q50052628-4E550FE4-19C4-4DE3-B575-ACC6B3CC9158Q52601345-FEFF7FD1-48BD-4933-9A3B-057F3877EA80Q52725925-71B9B977-20A4-4C87-8884-FE5CBD4B550EQ52804356-3BCAA660-8EBC-495F-A64E-B1FA0B74E37AQ56359583-E9BBD0A0-B885-4022-80D1-F4DB72576512
P2860
Charcot-Marie-Tooth 2B mutations in rab7 cause dosage-dependent neurodegeneration due to partial loss of function.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Charcot-Marie-Tooth 2B mutatio ...... e to partial loss of function.
@en
Charcot-Marie-Tooth 2B mutatio ...... e to partial loss of function.
@nl
type
label
Charcot-Marie-Tooth 2B mutatio ...... e to partial loss of function.
@en
Charcot-Marie-Tooth 2B mutatio ...... e to partial loss of function.
@nl
prefLabel
Charcot-Marie-Tooth 2B mutatio ...... e to partial loss of function.
@en
Charcot-Marie-Tooth 2B mutatio ...... e to partial loss of function.
@nl
P2093
P2860
P356
P1433
P1476
Charcot-Marie-Tooth 2B mutatio ...... ue to partial loss of function
@en
P2093
Chih-Chiang Chan
Daniel Epstein
Egemen Agi
Eugene Jennifer Jin
P Robin Hiesinger
Smita Cherry
Wei-Hung Jung
Zhiyuan Lu
P2860
P304
P356
10.7554/ELIFE.01064
P407
P577
2013-12-10T00:00:00Z